Skip to main content

Month: September 2024

Form 8.3 – [KEYWORDS STUDIOS PLC – 06 09 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Parsons Supports U.S. Indo-Pacific Defense With $68.5 Million U.S. Army Infrastructure Contract

CHANTILLY, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a contract by the United States Army Corps of Engineers (USACE) Honolulu District to provide the design-bid-build delivery of new U.S. Army housing units in the Kwajalein Atoll in the Republic of the Marshall Islands. The three-year, $68.5 million single-award contract is new work for the company. Parsons was also selected by the USACE Honolulu District as a successful offeror on the district’s Pre-Qualified Source Listing (PQSL), making the company eligible to receive future large task orders valued at $50 million or more in the district’s area of responsibility. “Parsons is a trusted delivery partner to the U.S. Army Corps of Engineers in advancing infrastructure projects that advance U.S. Indo-Pacific...

Continue reading

Bitfarms Reschedules Special Meeting of Shareholders

– Provides Update on Engagement with Riot –– Special Meeting to be Held In-Person –   This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, Sept. 09, 2024 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a global leader in vertically integrated Bitcoin data center operations, today announced that it has rescheduled the Special Meeting of shareholders (the “Special Meeting”) from October 29, 2024 to November 6, 2024. The Special Meeting has been called in response to a requisition made by Riot Platforms, Inc. (“Riot”) on June 24, 2024 and amended on September 3, 2024 (the “Amended Requisition”). The...

Continue reading

Man Group PLC : Form 8.3 – International Paper Co

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree International Paper Company(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan

Disclaimer: SAFE SA (the “Company”) has arranged financing in the form of convertible bonds into new or existing shares (OCEANE) with Global Corporate Finance Opportunities 20 (“GCFO 20”), which, after receiving the shares resulting from the conversion of these bonds, is not intended to remain a shareholder of the Company. The shares resulting from the conversion of these bonds will generally be sold on the market at very short notice, which may create strong downward pressure on the share price. Shareholders may suffer a loss of their invested capital due to a significant fall in the Company’s share price, as well as significant dilution due to the large number of securities issued to the GCFO 20 fund. Investors are advised to exercise extreme caution before deciding to invest in the securities of a listed company that carries...

Continue reading

Clean Motion strengthens team to increase production capacity – Martin Ericson appointed Head of Launch Management & Mechanical Engineering

Martin Ericson-2, Clean Motion ABMartin Ericson-1, Clean Motion ABClean Motion AB, which develops and manufactures electric vehicles with a focus on energy efficiency and sustainability, announces that Martin Ericson is assuming the role of Head of Launch Management & Mechanical Engineering as of today. This strategic recruitment marks an important step in the company’s journey to scale up production and meet the growing demand for EVIG. Jonsered, Sverige – 2024-09-09. Clean Motion AB strengthens its team with the addition of Martin Ericson, who assumes the role of Head of Launch Management & Mechanical Engineering. Martin, who most recently ran his own consultancy in product development and quality management, has a background in the automotive and aerospace industries. He previously held a leadership...

Continue reading

Immunovant Provides Update on Graves’ Disease Development Program

High dose batoclimab achieved 76% response rate in patients uncontrolled on antithyroid drugs (ATDs) at week 12 High dose batoclimab achieved 56% ATD-Free response rate in patients uncontrolled on ATDs at week 12 Strong correlation observed between degree of IgG lowering and clinical outcomes yields potential best-in-class and first-in-class opportunity for IMVT-1402 in Graves’ Disease (GD) Real world claims data indicates 25-30% of Graves’ Disease patients per year are uncontrolled on ATDs with minimal to no existing therapeutic options representing an attractive commercial opportunity with limited competition IND cleared with initiation of IMVT-1402 pivotal trial in GD expected by calendar year endNEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling...

Continue reading

21Shares Announces the Release of its Staking Research and Education Initiative, Focused on Market Education and Thought Leadership

ZURICH, 9 September 2024 – 21Shares AG (“21Shares”), one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs) and a subsidiary of 21.co, is pleased to announce a new initiative focussed on Staking, designed to educate the market on the basics of crypto staking, its potential benefits for ETP investors and 21Shares’ unique approach. “Staking is a way for crypto holders to put the digital assets they hold to work and earn a passive income without selling them, representing a potential opportunity for investors. Through our Staking Primer and education initiative, 21Shares seeks to introduce clients and potential investors to this key component of the crypto ecosystem,” said Adrian Fritz, Head of Research at 21Shares. “Since inception in 2018, 21Shares has provided world-class research and insights...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.